• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KS1/4单克隆抗体-去乙酰长春碱酰肼缀合物LY203725在大鼠和猴子体内的药代动力学及处置情况。

Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.

作者信息

Lindstrom T D, Althaus W A, Ruterbories K J, Kau D

机构信息

Department of Drug Metabolism and Disposition, Eli Lilly and Company, Indianapolis, Indiana.

出版信息

J Pharmacol Exp Ther. 1990 Mar;252(3):1117-24.

PMID:2319463
Abstract

The plasma pharmacokinetics of the monoclonal antibody-vinca conjugate KS 1/4-desacetylvinblastine hydrazide (DAVLB-hyd; [3H]LY203725) have been evaluated in rats (17 mg/kg) and monkeys (15 mg/kg) after i.v. dosing. Plasma concentrations of radioactivity 1 hr after dosing were higher in monkeys than in rats. The biphasic elimination of radioactivity in rats was characterized by half-lives (T1/2) of 10 and 143 hr, whereas the elimination of radioactivity in monkeys was characterized by T1/2 values of 11 and 66 hr. Plasma total antibody and radioactivity concentrations were similar within 6 (rat) and 24 (monkey) hr after dosing; however, total antibody concentrations were greater than radioactivity concentrations thereafter, indicating the presence of free antibody in the plasma. Plasma elimination T1/2 values and areas under the curve of total antibody in rats and monkeys were greater than those of radioactivity. The presence of free antibody implies the presence of free DAVLB-hyd; however, plasma concentrations of free DAVLB-hyd were at least 3 orders of magnitude less than those of radioactivity in both species. The T1/2 of free DAVLB-hyd in plasma of LY203725 dosed monkeys was 16 hr. Hydrolysis of the conjugate to yield free DAVLB-hyd was observed upon incubation of conjugate with rat plasma in vitro. Administration of DAVLB-hyd to rats resulted in a rapid initial decrease in plasma DAVLB-hyd followed by a slower (T1/2 = 1.4 hr) elimination rate. Fecal excretion was the predominant mode of elimination of radioactivity in both rats and monkeys dosed with [3H]LY203725.

摘要

在静脉注射给药后,已对单克隆抗体-长春花属植物缀合物KS 1/4-去乙酰长春碱酰肼(DAVLB-hyd;[3H]LY203725)在大鼠(17mg/kg)和猴子(15mg/kg)体内的血浆药代动力学进行了评估。给药1小时后,猴子体内放射性物质的血浆浓度高于大鼠。大鼠体内放射性物质的双相消除特征为半衰期(T1/2)分别为10小时和143小时,而猴子体内放射性物质的消除特征为T1/2值分别为11小时和66小时。给药后6小时(大鼠)和24小时(猴子)内,血浆总抗体和放射性浓度相似;然而,此后总抗体浓度大于放射性浓度,表明血浆中存在游离抗体。大鼠和猴子体内血浆消除T1/2值以及总抗体的曲线下面积均大于放射性物质的相应值。游离抗体的存在意味着游离DAVLB-hyd的存在;然而,在两个物种中,游离DAVLB-hyd的血浆浓度至少比放射性物质的血浆浓度低3个数量级。LY203725给药猴子血浆中游离DAVLB-hyd的T1/2为16小时。在体外将缀合物与大鼠血浆孵育时,观察到缀合物水解产生游离DAVLB-hyd。给大鼠注射DAVLB-hyd后,血浆中DAVLB-hyd最初迅速下降,随后消除速率减慢(T1/2 = 1.4小时)。在给予[3H]LY203725的大鼠和猴子中,粪便排泄是放射性物质消除的主要方式。

相似文献

1
Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.KS1/4单克隆抗体-去乙酰长春碱酰肼缀合物LY203725在大鼠和猴子体内的药代动力学及处置情况。
J Pharmacol Exp Ther. 1990 Mar;252(3):1117-24.
2
Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.单克隆抗体-长春花生物碱偶联物KS1/4-DAVLB(LY256787)在Fischer 344大鼠和恒河猴体内的处置情况。
Drug Metab Dispos. 1987 Sep-Oct;15(5):640-7.
3
Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
J Pharmacol Exp Ther. 1987 May;241(2):695-703.
4
Disposition of a murine monoclonal antibody vinca conjugate (KS1/4-DAVLB) in patients with adenocarcinomas.鼠单克隆抗体长春花共轭物(KS1/4 - DAVLB)在腺癌患者中的处置情况。
Clin Pharmacol Ther. 1990 Jan;47(1):36-41. doi: 10.1038/clpt.1990.5.
5
Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer.
Cancer Res. 1990 Jun 15;50(12):3540-4.
6
New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity.新型抗肿瘤单克隆抗体-长春花属植物缀合物LY203725及相关化合物:设计、制备及代表性体内活性
J Med Chem. 1989 Mar;32(3):548-55. doi: 10.1021/jm00123a007.
7
Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.新型促甲状腺素释放激素类似物水合蒙替瑞林的药代动力学。首次通讯:对大鼠、狗和猴子单次静脉给药后的血浆浓度、代谢及排泄情况
Arzneimittelforschung. 1996 Feb;46(2):106-13.
8
Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs.用于卵巢癌治疗的化学免疫缀合物研发:长春花生物碱-单克隆抗体构建体的临床前研究
Bioconjug Chem. 1993 Mar-Apr;4(2):121-6. doi: 10.1021/bc00020a003.
9
Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.人白细胞弹性蛋白酶的口服活性抑制剂。I. L-683,845在大鼠和恒河猴体内的处置情况。
Drug Metab Dispos. 1996 Dec;24(12):1369-77.
10
Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.环丙沙星的药代动力学。首次通讯:白化大鼠和恒河猴单次给予[14C]环丙沙星后的吸收、血浆浓度、代谢及排泄情况
Arzneimittelforschung. 1986 Oct;36(10):1496-502.